Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease

Fig. 2

A Average number of cells with high ɣH2AX after oleic acid or oleic acid plus metabolic inhibitor drug treatments (% compared to control cells). B Representative ɣH2AX immunofluorescence images of control and oleic acid-treated cells (blue nuclear stain, pink ɣH2AX). Error bars are ± SEM. All groups n = 6–8. *P < 0.05, ***P < 0.0001 in t-test of oleic vs oleic plus inhibitor groups

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us